Most Read Articles
3 days ago
Extending the use of the 53-mg levonorgestrel intrauterine device (IUD) and the T380A copper IUD results in reduced rates of pregnancy, adverse events, and discontinuation owing to side effects, which are also comparable to those during approved duration of use, a study has shown.
Roshini Claire Anthony, 30 Nov 2019

A target low-density lipoprotein cholesterol (LDL-C) level of <70 mg/dL appeared to reduce the risk of major cardiovascular (CV) events* following an atherosclerotic ischaemic stroke, according to results of the Treat Stroke to Target trial.

Roshini Claire Anthony, 28 Jun 2020

Roxadustat treatment for anaemia in patients with dialysis-dependent chronic kidney disease (DD CKD) does not come with an increased risk of ophthalmic abnormalities, according to a phase III trial conducted in Japan.

Elvira Manzano, 28 Jun 2020
Hyperkalaemia (HK) occurrence and recurrence are frequent in advanced CKD*, creating a perfect storm for cardiovascular events and death, says Professor Juan-Jesus Carrero from the Karolinska Institute, Solna, Sweden, at ERA-EDTA 2020. Given these risks, acutely elevated potassium (K+) should merit clinical attention.

Product Highlight - BELAFCAP

27 Jun 2020
  • Provides anti-oxidant substances which delay the aging process.
  • Strengthens the body’s resistance, helps prevent from diseases.
  • Helps recover strength for athletes, pupils reviewing for exams, people working under stress, convalescents.
  • Prevention and in combination therapy for vision diseases, nervous disorders (amnesia, Alzheimer’s, Parkinson’s), cancer, cardiovascular diseases.

Related MIMS Drugs

Editor's Recommendations
Most Read Articles
3 days ago
Extending the use of the 53-mg levonorgestrel intrauterine device (IUD) and the T380A copper IUD results in reduced rates of pregnancy, adverse events, and discontinuation owing to side effects, which are also comparable to those during approved duration of use, a study has shown.
Roshini Claire Anthony, 30 Nov 2019

A target low-density lipoprotein cholesterol (LDL-C) level of <70 mg/dL appeared to reduce the risk of major cardiovascular (CV) events* following an atherosclerotic ischaemic stroke, according to results of the Treat Stroke to Target trial.

Roshini Claire Anthony, 28 Jun 2020

Roxadustat treatment for anaemia in patients with dialysis-dependent chronic kidney disease (DD CKD) does not come with an increased risk of ophthalmic abnormalities, according to a phase III trial conducted in Japan.

Elvira Manzano, 28 Jun 2020
Hyperkalaemia (HK) occurrence and recurrence are frequent in advanced CKD*, creating a perfect storm for cardiovascular events and death, says Professor Juan-Jesus Carrero from the Karolinska Institute, Solna, Sweden, at ERA-EDTA 2020. Given these risks, acutely elevated potassium (K+) should merit clinical attention.